Tranexamic acid for percutaneous nephrolithotomy

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the effects of TXA in adults with kidney stones undergoing PCNL.

This is a protocol.

Published:

14 March 2022

Authors:

Cleveland B, Norling B, Wang H, Gandhi V, Price CL, Borofsky M, Pais V, Dahm P

Primary Review Group:

Print
PDF
Citation
Cleveland B, NorlingB, WangH, GandhiV, PriceCL, BorofskyM, PaisV, DahmP.Tranexamic acid for percutaneous nephrolithotomy (Protocol). Cochrane Database of Systematic Reviews 2022, Issue 3. Art. No.: CD015122. DOI: 10.1002/14651858.CD015122.